Ligand validation:3H1I

CDL: CARDIOLIPIN

CDL is a Ligand Of Interest in 3H1I designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
3H1I_CDL_C_2004	17%	39%	0.236	0.921	1.27	1.13	5	2	2	0	40%	0.4
3H1I_CDL_P_3004	9%	39%	0.268	0.872	1.26	1.13	4	2	2	0	40%	0.4
3H1I_CDL_D_2003	5%	46%	0.34	0.83	1.18	0.91	4	1	1	0	50%	0.5
3H1I_CDL_Q_3003	2%	46%	0.404	0.754	1.15	0.93	3	1	4	0	50%	0.5
3TGU_CDL_G_101	21%	41%	0.207	0.924	1.21	1.1	1	4	1	0	40%	0.4
3L74_CDL_G_2004	20%	43%	0.208	0.919	1.2	1.03	3	3	2	0	40%	0.4
3L75_CDL_G_2004	18%	41%	0.217	0.912	1.21	1.07	4	2	1	0	40%	0.4
3L71_CDL_T_3004	18%	41%	0.222	0.914	1.21	1.09	2	3	3	0	40%	0.4
3L70_CDL_C_2004	17%	41%	0.22	0.906	1.2	1.09	2	3	4	0	40%	0.4
5Y5S_CDL_M_415	41%	34%	0.128	0.953	1.32	1.27	3	3	1	0	39%	0.39
2GNU_CDL_M_1309	38%	22%	0.122	0.984	1.77	1.5	3	3	0	0	10%	10
3ZDQ_CDL_A_1721	37%	64%	0.215	0.943	0.72	0.65	4	4	0	1	84%	0.42
6JY3_CDL_B_301	33%	24%	0.163	0.908	1.53	1.57	5	14	0	0	64%	0.64
7COH_CDL_A_521	33%	72%	0.212	0.901	0.46	0.6	-	2	6	0	94%	0.94

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.